By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Ultragenyx Pharmaceuticals 

77 Digital Drive
Suite 210
Novato  California  94949  U.S.A.
Phone: 415-884-0223 Fax: 415-884-0562


SEARCH JOBS


Industry
Pharmaceutical






Company News
Ultragenyx Pharmaceuticals (RARE) To Present At The Leerink Partners Rare Disease Roundtable 9/24/2014 7:48:58 AM
Ultragenyx Pharmaceuticals (RARE) Announces Positive Results From A Long-Term Phase 1/2 Study Of KRN23 In Adult Patients With X-Linked Hypophosphatemia 9/15/2014 8:12:15 AM
Ultragenyx Pharmaceuticals (RARE) To Present At The Morgan Stanley (MST) Global Healthcare Conference 9/4/2014 10:21:59 AM
Ultragenyx Pharmaceuticals (RARE) Announces Positive Interim Data From Phase 1/2 Study Of Recombinant Human Beta-Glucuronidase In Mucopolysaccharidosis 7 9/3/2014 7:17:52 AM
Ultragenyx Pharmaceuticals (RARE) To Present At The Baird Health Care Conference 8/27/2014 8:01:17 AM
Ultragenyx Pharmaceuticals (RARE) Reports Second Quarter 2014 Financial Results And Corporate Update 8/11/2014 7:49:58 AM
Ultragenyx Pharmaceuticals (RARE) To Present At Upcoming Investor Conferences 8/6/2014 8:42:18 AM
Ultragenyx Pharmaceuticals (RARE) Announces License Of Intellectual Property For The Treatment Of Epilepsy And Other Seizure-Related Disorders With Triheptanoin 8/5/2014 8:41:11 AM
Ultragenyx Pharmaceuticals (RARE) Appoints Sunil Agarwal, M.D. As Chief Medical Officer And Senior Vice President 7/23/2014 1:01:02 PM
Ultragenyx Pharmaceuticals (RARE) Announces Closing Of Public Offering Of Common Stock And Exercise Of Underwriters' Option To Purchase Additional Shares 7/14/2014 12:26:45 PM
12345678
//-->